A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation.

MLA

Joossen, Cedric, et al. “A Novel Serine Protease Inhibitor as Potential Treatment for Dry Eye Syndrome and Ocular Inflammation.” Scientific Reports, vol. 10, no. 1, Oct. 2020, p. 17268. EBSCOhost, https://doi.org/10.1038/s41598-020-74159-w.

APA

Joossen, C., Baán, A., Moreno-Cinos, C., Joossens, J., Cools, N., Lanckacker, E., Moons, L., Lemmens, K., Lambeir, A.-M., Fransen, E., Delputte, P., Caljon, G., Van Der Veken, P., Maes, L., De Meester, I., Kiekens, F., Augustyns, K., & Cos, P. (2020). A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation. Scientific Reports, 10(1), 17268. https://doi.org/10.1038/s41598-020-74159-w

Chicago

Joossen, Cedric, Adrienn Baán, Carlos Moreno-Cinos, Jurgen Joossens, Nathalie Cools, Ellen Lanckacker, Lieve Moons, et al. 2020. “A Novel Serine Protease Inhibitor as Potential Treatment for Dry Eye Syndrome and Ocular Inflammation.” Scientific Reports 10 (1): 17268. doi:10.1038/s41598-020-74159-w.